246 related articles for article (PubMed ID: 34974856)
1. A Nanocrystals-Based Topical Drug Delivery System with Improved Dermal Penetration and Enhanced Treatment of Skin Diseases.
Sun L; Xiang H; Ge C; Chen X; Zhang Q; Zhang Y; Miao X
J Biomed Nanotechnol; 2021 Dec; 17(12):2319-2337. PubMed ID: 34974856
[TBL] [Abstract][Full Text] [Related]
2. Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery.
Patel V; Sharma OP; Mehta T
Expert Opin Drug Deliv; 2018 Apr; 15(4):351-368. PubMed ID: 29465253
[TBL] [Abstract][Full Text] [Related]
3. Nanocrystals for improved dermal drug delivery.
Pelikh O; Stahr PL; Huang J; Gerst M; Scholz P; Dietrich H; Geisel N; Keck CM
Eur J Pharm Biopharm; 2018 Jul; 128():170-178. PubMed ID: 29680482
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery.
Parmar PK; Wadhawan J; Bansal AK
Drug Discov Today; 2021 Oct; 26(10):2329-2349. PubMed ID: 34265460
[TBL] [Abstract][Full Text] [Related]
5. Improved Dermal and Transdermal Delivery of Curcumin with SmartFilms and Nanocrystals.
Eckert RW; Wiemann S; Keck CM
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804137
[TBL] [Abstract][Full Text] [Related]
6. Skin permeation of curcumin nanocrystals: Effect of particle size, delivery vehicles, and permeation enhancer.
Xiang H; Xu S; Zhang W; Li Y; Zhou Y; Miao X
Colloids Surf B Biointerfaces; 2023 Apr; 224():113203. PubMed ID: 36791520
[TBL] [Abstract][Full Text] [Related]
7. Nanocrystals as an emerging nanocarrier for the management of dermatological diseases.
Parveen N; Abourehab MAS; Thanikachalam PV; Khar RK; Kesharwani P
Colloids Surf B Biointerfaces; 2023 May; 225():113231. PubMed ID: 36907135
[TBL] [Abstract][Full Text] [Related]
8. Formulation design for topical drug and nanoparticle treatment of skin disease.
Raphael AP; Garrastazu G; Sonvico F; Prow TW
Ther Deliv; 2015 Feb; 6(2):197-216. PubMed ID: 25690087
[TBL] [Abstract][Full Text] [Related]
9. Advances in encapsulated dermal formulations in chemoprevention of melanoma: An overview.
Ravikumar P; Tatke P
J Cosmet Dermatol; 2019 Dec; 18(6):1606-1612. PubMed ID: 31436386
[TBL] [Abstract][Full Text] [Related]
10. Hydrogels for dermal and transdermal drug delivery.
Labie H; Blanzat M
Biomater Sci; 2023 Jun; 11(12):4073-4093. PubMed ID: 37060109
[TBL] [Abstract][Full Text] [Related]
11. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
[TBL] [Abstract][Full Text] [Related]
12. Current Applications and Benefits of Polymeric Nanocarriers for the Management of Skin Disorders.
Pierre MBR
Curr Med Chem; 2022; 29(38):5949-5964. PubMed ID: 35619267
[TBL] [Abstract][Full Text] [Related]
13. Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders.
Desmet E; Van Gele M; Lambert J
Expert Opin Drug Deliv; 2017 Jan; 14(1):109-122. PubMed ID: 27348356
[TBL] [Abstract][Full Text] [Related]
14. Hair follicle targeting with curcumin nanocrystals: Influence of the formulation properties on the penetration efficacy.
Pelikh O; Eckert RW; Pinnapireddy SR; Keck CM
J Control Release; 2021 Jan; 329():598-613. PubMed ID: 33011240
[TBL] [Abstract][Full Text] [Related]
15. Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin - assessment by intradermal microdialysis and extraction from the different skin layers.
Döge N; Hönzke S; Schumacher F; Balzus B; Colombo M; Hadam S; Rancan F; Blume-Peytavi U; Schäfer-Korting M; Schindler A; Rühl E; Skov PS; Church MK; Hedtrich S; Kleuser B; Bodmeier R; Vogt A
J Control Release; 2016 Nov; 242():25-34. PubMed ID: 27394682
[TBL] [Abstract][Full Text] [Related]
16. Nanocarrier-based topical drug delivery for the treatment of skin diseases.
Gupta M; Agrawal U; Vyas SP
Expert Opin Drug Deliv; 2012 Jul; 9(7):783-804. PubMed ID: 22559240
[TBL] [Abstract][Full Text] [Related]
17. Application of nanoparticles in percutaneous delivery of active ingredients in cosmetic preparations.
Khezri K; Saeedi M; Maleki Dizaj S
Biomed Pharmacother; 2018 Oct; 106():1499-1505. PubMed ID: 30119225
[TBL] [Abstract][Full Text] [Related]
18. Nile red nanosuspensions as investigative model to study the follicular targeting of drug nanocrystals.
Corrias F; Schlich M; Sinico C; Pireddu R; Valenti D; Fadda AM; Marceddu S; Lai F
Int J Pharm; 2017 May; 524(1-2):1-8. PubMed ID: 28336458
[TBL] [Abstract][Full Text] [Related]
19. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
Lauterbach A; Müller-Goymann CC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
[TBL] [Abstract][Full Text] [Related]
20. Polymeric and lipid-based materials for topical nanoparticle delivery systems.
Pawar KR; Babu RJ
Crit Rev Ther Drug Carrier Syst; 2010; 27(5):419-59. PubMed ID: 21083529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
